Unicon Optical Co., Ltd. (TPEX:4150)
6.93
-0.07 (-1.00%)
At close: Feb 11, 2026
Unicon Optical Revenue
Unicon Optical had revenue of 294.53M TWD in the half year ending June 30, 2025, a decrease of -20.71%. This brings the company's revenue in the last twelve months to 747.16M, down -19.75% year-over-year. In the year 2024, Unicon Optical had annual revenue of 909.45M with 7.54% growth.
Revenue (ttm)
747.16M
Revenue Growth
-19.75%
P/S Ratio
1.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 909.45M | 63.78M | 7.54% |
| Dec 31, 2023 | 845.67M | 20.23M | 2.45% |
| Dec 31, 2022 | 825.44M | -72.64M | -8.09% |
| Dec 31, 2021 | 898.08M | -215.58M | -19.36% |
| Dec 31, 2020 | 1.11B | -122.62M | -9.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.20B |
| Nang Kuang Pharmaceutical | 2.22B |
| Bionime | 1.91B |
| Chi Sheng Pharma & Biotech | 1.36B |
| ICARES Medicus | 1.09B |
| Crystalvue Medical | 905.73M |
| Concord Medical | 905.31M |
| Maxigen Biotech | 792.49M |